Custom Search
Demographics
Distribution
The report is distributed to 8000+ key decision makers worldwide within the pharmaceutical and biotech sectors.
CEO/MD/Company Directors 24%
Business Development and Licensing 46%
Life Cycle Management and Product Line Extensions 4%
Research and Development 5%
Formulation and Pharmaceutics 5%
Drug Delivery Development and Evaluation 10%
Sourcing/Purchasing/Outsourcing 6%
Global reach
Target organisations
Big pharmaceutical companies
Small to medium sized biotechnology and pharmaceutical companies who are actively assessing new delivery technology
Advertisers will receive additional exposure to their company's activities through visitors to drugdeliveryreport.com
Search
Custom Search
Archives
- An Assessment of Six Months of Drug
- Nanotechnology for Drug Delivery: a Validated Technology?
- Facing the Challenge of Broadening the Benefit Spectrum
- Breathing Life into Inhaler Design
- Making Technology Work
- Marketing and Acquisitions Activity in the Drug Delivery Industry
- Current Trends in Global Pharmaceutical Licensing
- Trends Within the Drug Delivery Sector – Therapy Focus
- Inhalation Technologies – A Breath of Fresh Air
- A Renaissance in Peptide Therapeutics is Underway